OMX Copenhagen 25 GI (OMXC25GI.CO)

Close: 2 073.61 (+27.20), Oct 15, 2021
Positive

Low risk

Automatic technical analysis. Medium term, Oct 15, 2021

OMX Copenhagen 25 GI is in a rising trend channel in the medium long term. This shows that investors over time have bought the index at higher prices and indicates good development for the market. The index has support at points 1850 and resistance at points 2200. The index is assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 72)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.95%0.00+1.33%
5 days0.002.92%0.00+3.22%
22 days0.007.31%0.00-2.74%
66 days0.0015.01%0.00+0.28%

More analyses of OMX Copenhagen 25 GI

chart OMX Copenhagen 25 GI (OMXC25GI) Candlesticks 22 Days
Candlesticks
chart OMX Copenhagen 25 GI (OMXC25GI) Short term
Short term: Weak Positive
chart OMX Copenhagen 25 GI (OMXC25GI) Medium term
Medium term: Positive
chart OMX Copenhagen 25 GI (OMXC25GI) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK